Gilead indicators a US$4.9 billion acquisition deal with Forty Seven Gilead indicators a US$4.9 billion acquisition deal with Forty Seven By admin on March 3, 2020 The deal would enhance Gilead’s portfolio in Oncology and would enable the agency to conduct new First-in-Class oncology applications. Gilead Sciences Inc., a U.S. primarily…